A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke
Public ClinicalTrials.gov record NCT04309474. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke
Study identification
- NCT ID
- NCT04309474
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Interventions
- Elezanumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 8, 2020
- Primary completion
- Apr 17, 2024
- Completion
- Dec 22, 2024
- Last update posted
- Dec 21, 2025
2020 – 2024
United States locations
- U.S. sites
- 22
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona /ID# 214957 | Phoenix | Arizona | 85054 | — |
| Long Beach Medical Center /ID# 217210 | Long Beach | California | 90808-1731 | — |
| Georgetown University Hospital /ID# 216481 | Washington D.C. | District of Columbia | 20007 | — |
| Duplicate_Mayo Clinic /ID# 217567 | Jacksonville | Florida | 32224 | — |
| Northwestern University Feinberg School of Medicine /ID# 215047 | Chicago | Illinois | 60611-2927 | — |
| Duplicate_University of Kentucky Chandler Medical Center /ID# 216394 | Lexington | Kentucky | 40536 | — |
| University of Louisville Hospital /ID# 217569 | Louisville | Kentucky | 40202 | — |
| Tufts Medical Center /ID# 215053 | Boston | Massachusetts | 02111-1552 | — |
| University of Mississippi Medical Center /ID# 217587 | Jackson | Mississippi | 39216-4500 | — |
| St. Luke's Marion Bloch Neuroscience Institute /ID# 215028 | Kansas City | Missouri | 64111-3220 | — |
| Washington University-School of Medicine /ID# 214526 | St Louis | Missouri | 63110 | — |
| Hackensack Univ Med Ctr /ID# 218200 | Hackensack | New Jersey | 07601 | — |
| University of New Mexico School of Medicine /ID# 216827 | Albuquerque | New Mexico | 87131-0001 | — |
| Columbia University Medical Center /ID# 215122 | New York | New York | 10032-3729 | — |
| UH Cleveland Medical Center /ID# 215372 | Cleveland | Ohio | 44106 | — |
| Cleveland Clinic Main Campus /ID# 214635 | Cleveland | Ohio | 44195 | — |
| The Ohio State University /ID# 215036 | Columbus | Ohio | 43210 | — |
| Lehigh Valley Health Network /ID# 242446 | Allentown | Pennsylvania | 18103 | — |
| Thomas Jefferson University Hospital /ID# 215469 | Philadelphia | Pennsylvania | 19107 | — |
| University of Texas Health Science Center at Houston /ID# 215018 | Houston | Texas | 77030-1501 | — |
| Baylor Scott & White Medical Center- Temple /ID# 225513 | Temple | Texas | 76508-0001 | — |
| University of Virginia /ID# 215757 | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04309474, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04309474 live on ClinicalTrials.gov.